Circulating Free DNA (cfdna) and Tissue Next-Generation Sequencing Analysis in a Phase II Study of Infigratinib (BGJ398) for Cholangiocarcinoma with FGFR2 Fusions.
Journal of Clinical Oncology(2020)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2020)